1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Thalassaemia International Federation (TIF) shared a grateful post on LinkedIn:
”What an unforgettable journey in Washington D.C.!
As we look back on the 1st TIF Pan American Conference and the 2nd RAIN Summit, we are deeply grateful to our incredible Sponsors who helped turn this vision into reality.
Your generous support empowered vital conversations and new connections among the Thalassaemia, SCD, and Rare Anaemias communities across the Americas.
Thank you for standing with us — for care, for science, for hope!”
The 1st TIF Pan American Conference and 2nd RAIN Summit in Washington D.C. marked an unforgettable milestone for the Thalassaemia, SCD, and Rare Anaemias communities.
TIF thanked all the sponsors: Agios Pharmaceuticals, Bristol Myers Squibb, Vertex Pharmaceuticals, bluebird bio, Chiesi Global Rare Diseases, Novo Nordisk and Sanofi.
Thanks to the support of dedicated sponsors, vital conversations and new collaborations flourished—advancing care, science, and hope across the Americas.
Do not miss the latest updates on the waves in the hematology field, read Hemostasis Today.
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS
-
Jan 29, 2026, 04:42Jecko Thachil on ‘Break Through’ Thrombosis Despite DOAC Use
-
Jan 28, 2026, 13:55Ney Carter Borges on Colchicine As 2ry Prevention in Atherosclerotic CVD
-
Jan 28, 2026, 13:35Louise St Germain Bannon Invites You to Submit Your Work to JTH and RPTH
-
Jan 28, 2026, 13:26Livia Stanger and Colleagues Link CS014 to in Vivo Thrombosis
-
Jan 28, 2026, 13:14Robert Campbell Congratulates Izabella Andrianova for Her Recent Publication in JTH